Figure 1
Odds ratios with 95% confidence limits for clinically relevant toxicity by genotype. (a) Outcome A: Grade 3–4 toxicity after cycle 1 or 2, delay or dose reductions of cycle 2 or 3. (b) Outcome B: Worst grade 3–4 toxicity, all cycles.
Figure 1 | The Pharmacogenomics Journal
